Please try another search
Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing a disease-modifying approach to target underlying cause of Alzheimer's disease (AD). The Company is focused on advancing a targeted immunotherapy drug candidate, ACU193, and establishing proof of mechanism in early AD patients. The Company's ACU193 is a humanized monoclonal antibody that selectively targets the anti-amyloid-beta oligomer (AbOs), has demonstrated functional and protective effects in in-vitro assays, and has demonstrated in-vivo safety and pharmacologic activity in multiple animal species including transgenic models for AD. The Company's therapeutic approach focuses on targeting AbOs, which is a toxic and pathogenic form of Ab relative to Ab monomers and amyloid plaques. The Company is developing ACU193 for intravenous (IV), administration every four weeks for the treatment of early AD, which is in Phase I clinical trial.
Name | Age | Since | Title |
---|---|---|---|
Sean Stalfort | 52 | 2018 | Independent Chairman of the Board |
Jeffrey L. C. Ives | 71 | 2014 | Independent Director |
Kimberlee Cobleigh Drapkin | 54 | 2022 | Independent Director |
Laura Stoppel | 36 | 2020 | Independent Director |
Nathan B. Fountain | 60 | 2021 | Independent Director |
Jeffrey L. Cummings | 73 | - | Member of Clinical & Scientific Advisory Board |
Reisa Sperling | - | - | Member of Clinical & Scientific Advisory Board |
Stephen Salloway | - | - | Member of Clinical & Scientific Advisory Board |
Cynthia A. Lemere | - | - | Member of Clinical & Scientific Advisory Board |
Colin Louis Masters | 76 | - | Member of Clinical & Scientific Advisory Board |
Derrell D. Porter | 52 | 2023 | Independent Director |
Lennart Mucke | - | 2022 | Member of the Scientific Advisory Board |
Michael A. Weiner | 76 | - | Member of Clinical & Scientific Advisory Board |
Steven T. DeKosky | - | - | Member of Clinical & Scientific Advisory Board |
Daniel J. O'Connell | 53 | 2006 | CEO & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review